Race against time: drug given before transfer could save stroke patients from severe disability
NCT ID NCT07203625
Summary
This study is testing if giving a clot-busting drug (tenecteplase) to stroke patients before they are transferred to a specialized hospital for a clot-removal procedure leads to better recovery. It focuses on patients with a severe type of stroke caused by a blockage in a major brain artery, who arrive at a hospital 4.5 to 24 hours after symptoms start. The main goal is to see if this early drug treatment helps more patients regain independence and avoid severe disability.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xuanwu Hospital, Capital Medical University
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.